Dramatic New Findings Concerning Increases in Substance Abuse Treatment Admissions Involving Non-Medical Use of Prescription Narcotic Pain Relievers to be Revealed at SAMHSA and ONDCP Conference

Date: 7/13/2010 12:05 AM
Media Contact: SAMHSA Press Office
Telephone: 240-276-2130

The Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) and the White House Office of National Drug Control Policy (ONDCP) will unveil the results of a new national survey which reveals a dramatic rise in the proportion of all substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers.

WHO:

Gil Kerlikowske, Director, White House Office of National Drug Control Policy

RADM Peter Delany, Director, SAMHSA’s Office of Applied Studies

Governor Jack Markell of Delaware

Michelle M. Leonhart, Acting Administrator, Drug Enforcement Administration

A. Thomas McLellan, Deputy Director, White House Office of National Drug Control Policy

Chris Kennedy Lawford, Author/Activist/Actor

WHEN:

Thursday, July 15, 2010, 10:00 am

WHERE:

National Press Building
Zenger Room, 13th Floor
529 14th Street, NW
Washington , D.C.

SAMHSA is a public health agency within the Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America’s communities.